Fingerprint
Dive into the research topics of 'Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction
Hagai Tavori, Michelle Melone, Shirya Rashid
Research output: Contribution to journal › Review article › peer-review
14
Scopus
citations